Close

Piper Sandler Downgrades Alnylam Pharmaceuticals (ALNY) to Neutral

August 4, 2021 4:00 AM EDT Send to a Friend
Piper Sandler analyst Edward Tenthoff downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login